Pharmaceutics International Inc (Pii) has appointed John Fowler as president and CEO effective March 7, 2022.   

Mr. Fowler, a seasoned veteran with more than 30 years of experience in the pharmaceutical and chemical industries, brings substantial commercial and operational capabilities to the organization and has a strong track record of driving performance and delivering growth. He has held numerous leadership positions in the pharmaceutical industry most recently serving as president and chief operating officer of Piramal Pharma Solutions, a global contract development and manufacturing organization (CDMO).

“We are very excited that John is joining Pii as our new president and CEO,” said Syed Abidi, founder and chairman, Pii. “John brings a wealth of industry knowledge with deep operational and leadership experience. We are confident John’s experience and leadership skills will enable Pii to meet the needs of its customers and the patients they serve.”

Mr. Fowler holds a chemical engineering degree from Bucknell University and an MBA from St. Joseph University. Prior to joining Piramal, he was the divisional CEO of the global fine chemical business at Johnson Matthey.